Mankind Pharma Q2 profit jumps 39% to ₹712 crore as revenue rises 17%

Mankind Pharma’s operating margin widened to 27% from 24.9% a year earlier. Its board also approved plans to merge two wholly owned subsidiaries into the company.

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)